Modeling the Novel Coronavirus (SARS-CoV-2) Outbreak in Sicily, Italy

被引:23
|
作者
Maugeri, Andrea [1 ]
Barchitta, Martina [1 ]
Battiato, Sebastiano [2 ]
Agodi, Antonella [1 ,3 ]
机构
[1] Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, I-95123 Catania, Italy
[2] Univ Catania, Dept Math & Comp Sci, I-95123 Catania, Italy
[3] Azienda Ospedal Univ Policlin Vittorio Emanue, I-95123 Catania, Italy
关键词
novel coronavirus; COVID-19; epidemic model; epidemiology;
D O I
10.3390/ijerph17144964
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Italy was the first country in Europe which imposed control measures of travel restrictions, quarantine and contact precautions to tackle the epidemic spread of the novel coronavirus (SARS-CoV-2) in all its regions. While such efforts are still ongoing, uncertainties regarding SARS-CoV-2 transmissibility and ascertainment of cases make it difficult to evaluate the effectiveness of restrictions. Here, we employed a Susceptible-Exposed-Infectious-Recovered-Dead (SEIRD) model to assess SARS-CoV-2 transmission dynamics, working on the number of reported patients in intensive care unit (ICU) and deaths in Sicily (Italy), from 24 February to 13 April. Overall, we obtained a good fit between estimated and reported data, with a fraction of unreported SARS-CoV-2 cases (18.4%; 95%CI = 0-34.0%) before 10 March lockdown. Interestingly, we estimated that transmission rate in the community was reduced by 32% (95%CI = 23-42%) after the first set of restrictions, and by 80% (95%CI = 70-89%) after those adopted on 23 March. Thus, our estimates delineated the characteristics of SARS-CoV2 epidemic before restrictions taking into account unreported data. Moreover, our findings suggested that transmission rates were reduced after the adoption of control measures. However, we cannot evaluate whether part of this reduction might be attributable to other unmeasured factors, and hence further research and more accurate data are needed to understand the extent to which restrictions contributed to the epidemic control.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [41] Exposure of hospital healthcare workers to the novel coronavirus (SARS-CoV-2)
    Razvi, Salman
    Oliver, Rahima
    Moore, Jonathan
    Beeby, Andrew
    CLINICAL MEDICINE, 2020, 20 (06) : E238 - E240
  • [42] An overview of the Novel Coronavirus (SARS-CoV-2) crisis in Fiji: Correspondence
    Prakash, Krishneel
    Khan, Nazia
    INTERNATIONAL JOURNAL OF SURGERY, 2021, 92
  • [43] Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2)
    Van Giau Vo
    Eva Bagyinszky
    Kyuhwan Shim
    Yoon Soo Park
    Seong Soo A. An
    Molecular & Cellular Toxicology, 2020, 16 : 355 - 357
  • [44] Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2)
    Vo, Van Giau
    Bagyinszky, Eva
    Shim, Kyuhwan
    Park, Yoon Soo
    An, Seong Soo A.
    MOLECULAR & CELLULAR TOXICOLOGY, 2020, 16 (04) : 355 - 357
  • [45] Novel Coronavirus (SARS-CoV-2) Pandemic: Overview and Current Status
    Alp, Sehnaz
    Unal, Serhat
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2020, 25 (02): : 111 - 120
  • [46] Novel Inhibitors of 2′-O-Methyltransferase of the SARS-CoV-2 Coronavirus
    Sulimov, Alexey
    Kutov, Danil
    Ilin, Ivan
    Xiao, Yibei
    Jiang, Sheng
    Sulimov, Vladimir
    MOLECULES, 2022, 27 (09):
  • [47] Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020
    Bordi, Licia
    Nicastri, Emanuele
    Scorzolini, Laura
    Di Caro, Antonino
    Capobianchi, Maria R.
    Castilletti, Concetta
    Lalle, Eleonora
    EUROSURVEILLANCE, 2020, 25 (08) : 2 - 5
  • [48] Stercoraceous transmission of SARS-CoV-2 (Coronavirus)
    Felsenreich, Daniel Moritz
    Gachabayov, Mahir
    Lee, Hanjoo
    Kumar, Anila
    Bergamaschi, Roberto
    SURGICAL TECHNOLOGY INTERNATIONAL-INTERNATIONAL DEVELOPMENTS IN SURGERY AND SURGICAL RESEARCH, 2020, 37
  • [49] Coronaviruses and New Coronavirus SARS-CoV-2
    Gurlevik, Sibel Lacinel
    JOURNAL OF PEDIATRIC INFECTION, 2020, 14 (01): : 46 - 48
  • [50] Androgens in SARS-CoV-2 Coronavirus Infections
    Starka, Luboslav
    Duskova, Michaela
    PHYSIOLOGICAL RESEARCH, 2021, 70 : S145 - S151